Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline / 부인종양
Journal of Gynecologic Oncology
;
: e30-2016.
Article
in English
| WPRIM
| ID: wpr-213436
ABSTRACT
After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Uterine Cervical Neoplasms
/
Age Factors
/
Treatment Outcome
/
Practice Guidelines as Topic
/
Papillomavirus Vaccines
/
Republic of Korea
/
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Type of study:
Practice guideline
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Journal of Gynecologic Oncology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS